Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 22;8(11):1074.
doi: 10.3390/children8111074.

Treatment Considerations for Obstructive Sleep Apnea in Pediatric Down Syndrome

Affiliations
Review

Treatment Considerations for Obstructive Sleep Apnea in Pediatric Down Syndrome

Erica Gastelum et al. Children (Basel). .

Abstract

Children with Down syndrome (DS) are at high risk for developing obstructive sleep apnea (OSA) compared to children without DS. The negative impact of OSA on health, behavior, and cognitive development in children with DS highlights the importance of timely and effective treatment. Due to the higher prevalence of craniofacial and airway abnormalities, obesity, and hypotonia in patients with DS, residual OSA can still occur after exhausting first-line options. While treatment commonly includes adenotonsillectomy (AT) and continuous positive airway pressure (CPAP) therapy, additional therapy such as medical management and/or adjuvant surgical procedures need to be considered in refractory OSA. Given the significant comorbidities secondary to untreated OSA in children with DS, such as cardiovascular and neurobehavioral consequences, more robust randomized trials in this patient population are needed to produce treatment guidelines separate from those for the general pediatric population of otherwise healthy children with OSA. Further studies are also needed to look at desensitization and optimization of CPAP use in patients with DS and OSA.

Keywords: Down syndrome; adenotonsillectomy; continuous positive airway pressure; obstructive sleep apnea; pediatric; trisomy 21.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of study selection. DS: Down Syndrome.

Similar articles

Cited by

References

    1. Parker S.E., Mai C.T., Canfield M.A., Rickard R., Wang Y., Meyer R.E., Anderson P., Mason C.A., Collins J.S., Kirby R.S., et al. National Birth Defects Prevention Network. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004–2006. Birth Defects Res. A Clin. Mol. Teratol. 2010;88:1008–1016. doi: 10.1002/bdra.20735. - DOI - PubMed
    1. Weijerman M.E., de Winter J.P. Clinical practice. The care of children with Down syndrome. Eur. J. Pediatrics. 2010;169:1445–1452. doi: 10.1007/s00431-010-1253-0. - DOI - PMC - PubMed
    1. Qubty W.F., Mrelashvili A., Kotagal S., Lloyd R.M. Comorbidities in infants with obstructive sleep apnea. J. Clin. Sleep Med. 2014;10:1213–1216. doi: 10.5664/jcsm.4204. - DOI - PMC - PubMed
    1. Maris M., Verhulst S., Wojciechowski M., Van de Heyning P., Boudewyns A. Prevalence of Obstructive Sleep Apnea in Children with Down Syndrome. Sleep. 2016;39:699–704. doi: 10.5665/sleep.5554. - DOI - PMC - PubMed
    1. Lee C.F., Lee C.H., Hsueh W.Y., Lin M.T., Kang K.T. Prevalence of Obstructive Sleep Apnea in Children with Down Syndrome: A Meta-Analysis. J. Clin. Sleep Med. 2018;14:867–875. doi: 10.5664/jcsm.7126. - DOI - PMC - PubMed

LinkOut - more resources